36 citations
,
November 2016 in “European journal of dermatology/EJD. European journal of dermatology”
This review examines systemic drugs that can cause changes in haircolor and emphasizes the importance of reporting these adverse events, but it does not include new clinical outcomes.
June 2021 in “Clinical neuropsychopharmacology and therapeutics”
This paper reviews the haircolorchanges associated with valproic acid treatment, noting only a few reported instances of bleaching or darkening, and reports no new findings.
This case study reports a man with rapid hair thinning, whitening, and sparse beard, linked to an increased proportion of hair follicles in catagen or telogen phase and peribulbar lymphocytic infiltrate.
The user is experiencing severe hair loss and colorchange despite low testosterone levels and healthy lifestyle changes. They have tried ketoconazole shampoo and consulted a dermatologist, who found no scalp issues but suggested using Toppik for coverage.
A 20-year-old male experienced bald spots and used minoxidil, which led to hair regrowth but also premature graying. He seeks advice on reversing graying through diet or supplements like catalase, while another user suggests vitamin D3 and sesame for haircolor.
The user is using oral minoxidil for hair growth and is considering adding topical latanoprost, but is concerned about potential eye colorchange. They are seeking advice on the effectiveness of latanoprost for hair thickening and the risk of eye colorchange.
Is scalp micropigmentation safe?Providers describe scalp micropigmentation as low-risk when a trained practitioner uses sterile single-use equipment, but that is a provider claim rather than a regulatory finding: pigment allergy, infection and colour change are documented risks of cosmetic tattooing.